Clinical trial · Interventional
TOGETHER: Track Outcomes and Guidance, Technology for Health and Effective Resources
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this project is to iteratively develop and test a TOGETHER pilot mobile app product in preparation for commercialization. TOGETHER is a mobile application on a smart software system that informal caregivers can use to develop and implement home-based care for cancer patients/survivors. The Technical Objectives are to: 1. Establish the project team and obtain stakeholder feedback on what to include in the product. 2. Evaluate IT customization requirements and HIPAA compliance security, and privacy protocols. 3. Develop a prototype to show NCI and then a pilot version for beta and usability testing among stakeholders. 4. Enhance interoperability and test integration into health system(s) - if feasible. 5. Develop user support documentation for stakeholders.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Use of TOGETHERCare app | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Beta Testing
- description
- For the beta testing, input will be provided by cancer patient/survivor, caregivers, and clinicians. TOGETHER app will be downloaded on smart phone. Subjects will be asked to answer questions and/or perform activities on his/her smartphone device. Project information will include responses to surveys and giving additional feedback on app user experience.
- interventionNames
- Behavioral: Use of TOGETHERCare app
- type
- EXPERIMENTAL
- label
- Usability testing
- description
- For the usability testing, caregivers will be the primary type of stakeholder providing input. TOGETHER app will be downloaded on smart phone. Subjects will be asked to answer questions and/or perform activities on his/her smartphone device. Project information will include responses to surveys and giving additional feedback on app user experience.
- interventionNames
- Behavioral: Use of TOGETHERCare app
Primary outcomes (6)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults (aged 18 years or older) who are either: * Cancer patient/survivor receiving care or with plans to transition to care in the community setting. * Caregiver of cancer patient/survivor receiving care or with plans to transition to care in the community setting. * Clinician of cancer patient/survivor receiving care or with plans to transition to care in the community setting. * Cancer patient is a patient of Stanford Health Care. * Patient, Caregiver, and Clinician are willing to be connected on the app. * Have a smartphone and data plan that allows for app installation and usage. * Must speak, read and write in English, because all study materials and communication will be in English. Exclusion Criteria: * Patient does not have a cancer diagnosis. * Cancer patient/survivor is not receiving care or does not have plans to transition to care in the community setting. * Cancer patient is not a patient of Stanford Health Care. * Patient, Caregiver, and Clinician are not willing to be connected on the app. * Unable to speak, read and write in English. * Does not have a smartphone nor data plan that allows for app installation and usage
References
Publications (1)
- RESULTOakley-Girvan I, Davis SW, Kurian A, Rosas LG, Daniels J, Palesh OG, Mesia RJ, Kamal AH, Longmire M, Divi V. Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study. JMIR Form Res. 2021 Aug 13;5(8):e22608. doi: 10.2196/22608. PMID 34398787